Volunteer Assignments and Opportunities: Difference between revisions
| [unchecked revision] | [unchecked revision] |
Snehal.Patel (talk | contribs) No edit summary |
No edit summary |
||
| Line 226: | Line 226: | ||
| | | | ||
|- | |- | ||
|'''''Acute Myeloid Leukemia (AML) and Related Precursor Neoplasms'''''||'''''Overview'''''||Daynna Wolff+Path Resident | |'''''Acute Myeloid Leukemia (AML) and Related Precursor Neoplasms'''''||'''''Overview'''''||Daynna Wolff+Daniel Butler (Path Resident) | ||
|Jennelle Hodge (JH)/ Malini Sathanoori (MS) | |Jennelle Hodge (JH)/ Malini Sathanoori (MS) | ||
|Complete | |Complete | ||
| Line 237: | Line 237: | ||
| | | | ||
|- | |- | ||
| Acute Myeloid Leukaemia with Germline CEBPA Mutation||Disease||Daynna Wolff+Path Resident||JH / MS | | Acute Myeloid Leukaemia with Germline CEBPA Mutation||Disease||Daynna Wolff+Matthew Kilpatrick (Path Resident)||JH / MS | ||
|PENDING | |PENDING | ||
| | | | ||
| Line 262: | Line 262: | ||
| | | | ||
|- | |- | ||
| Myeloid Neoplasms with Germline GATA2 Mutation||Disease||Daynna Wolff+Path Resident||JH / MS | | Myeloid Neoplasms with Germline GATA2 Mutation||Disease||Daynna Wolff+ Alexandria Avery (Path Resident)||JH / MS | ||
|Complete | |Complete | ||
| | | | ||
| | | | ||
|- | |- | ||
|'''''Acute Myeloid Leukemia (AML) with Recurrent Genetic Abnormalities'''''||'''''Overview'''''||Daynna Wolff+ | |'''''Acute Myeloid Leukemia (AML) with Recurrent Genetic Abnormalities'''''||'''''Overview'''''||Daynna Wolff+ Dan Wang (trainee) | ||
|JH / MS | |JH / MS | ||
|Complete | |Complete | ||
| Line 308: | Line 308: | ||
| | | | ||
|- | |- | ||
| Acute Myeloid Leukemia (AML) with BCR-ABL1||Disease||Kay Weng | | Acute Myeloid Leukemia (AML) with BCR-ABL1||Disease||Kay Weng Choy + Greg Conboy (Monash Health)||JH / MS | ||
|Complete | |Complete | ||
| | | | ||
| | | | ||
|- | |- | ||
| Acute Myeloid Leukemia (AML) with Mutated NPM1||Disease||Xinjie Xu+Kay Weng Choy | | Acute Myeloid Leukemia (AML) with Mutated NPM1||Disease||Xinjie Xu+Kay Weng Choy + Greg Conboy (Monash Health)||JH / MS | ||
|Complete | |Complete | ||
| | | | ||
|Add WHO reference | |Add WHO reference | ||
|- | |- | ||
| Acute Myeloid Leukemia (AML) with Biallelic Mutations of CEBPA||Disease||Paul deFazio, MSc | | Acute Myeloid Leukemia (AML) with Biallelic Mutations of CEBPA||Disease||Paul deFazio, MSc + Greg Conboy (Monash Health)||JH / MS | ||
|Complete | |Complete | ||
| | | | ||
| | | | ||
|- | |- | ||
| Acute Myeloid Leukemia (AML) with Mutated RUNX1||Disease||Daynna Wolff+Path Resident | | Acute Myeloid Leukemia (AML) with Mutated RUNX1||Disease||Daynna Wolff+Iris Martin (Path Resident)||JH / MS | ||
|Complete | |Complete | ||
| | | | ||
| Line 333: | Line 333: | ||
| | | | ||
|- | |- | ||
|Therapy-Related Myeloid Neoplasms||Disease||Shashi Shetty + resident||JH / MS | |Therapy-Related Myeloid Neoplasms||Disease||Shashi Shetty + Shawn A. Silver (resident)||JH / MS | ||
|Complete | |Complete | ||
| | | | ||
|Check reference format | |Check reference format | ||
|- | |- | ||
|''Acute Myeloid Leukemia (AML), Not Otherwise Specified''||'''''Overview'''''||Anwar | |''Acute Myeloid Leukemia (AML), Not Otherwise Specified''||'''''Overview'''''||Anwar Iqbal||JH / MS | ||
|Complete | |Complete | ||
| | | | ||
| Line 383: | Line 383: | ||
| | | | ||
|- | |- | ||
| Acute Panmyelosis with Myelofibrosis||Disease||Ying Zou and | | Acute Panmyelosis with Myelofibrosis||Disease||Ying Zou and Jialing Huang||JH / MS | ||
|Complete | |Complete | ||
| | | | ||
| Line 408: | Line 408: | ||
| | | | ||
|- | |- | ||
|Blastic Plasmacytoid Dendritic Cell Neoplasm||Disease||Daynna Wolff+Path Resident||JH / MS | |Blastic Plasmacytoid Dendritic Cell Neoplasm||Disease||Daynna Wolff+Hao Liu (Path Resident)||JH / MS | ||
|Complete | |Complete | ||
| | | | ||
| Line 418: | Line 418: | ||
| | | | ||
|- | |- | ||
| Acute Undifferentiated Leukemia||Disease||Shashi Shetty + resident||JH / MS | | Acute Undifferentiated Leukemia||Disease||Shashi Shetty + Amelia Nakanishi (resident)||JH / MS | ||
|Complete | |Complete | ||
| | | | ||
| Line 433: | Line 433: | ||
| | | | ||
|- | |- | ||
| Mixed Phenotype Acute Leukemia (MPAL), B/Myeloid, Not Otherwise Specified||Disease||Shashi Shetty + resident||JH / MS | | Mixed Phenotype Acute Leukemia (MPAL), B/Myeloid, Not Otherwise Specified||Disease||Shashi Shetty + Priyatharsini Nirmalanantham (resident)||JH / MS | ||
|Complete | |Complete | ||
| | | | ||
| Line 455: | Line 455: | ||
|Acute Myeloid Leukemia (AML) with Mutated FLT3 | |Acute Myeloid Leukemia (AML) with Mutated FLT3 | ||
|Disease | |Disease | ||
|Kay Weng | |Kay Weng Choy + Greg Conboy (Monash Health) | ||
|JH / MS | |JH / MS | ||
|Complete | |Complete | ||
| Line 463: | Line 463: | ||
|Acute Myeloid Leukemia (AML) with NUP214-ABL1 | |Acute Myeloid Leukemia (AML) with NUP214-ABL1 | ||
|Disease | |Disease | ||
|Daynna Wolff+Path Resident | |Daynna Wolff+Jessica Snider (Path Resident) | ||
|JH / MS | |JH / MS | ||
|PENDING | |PENDING | ||
| Line 471: | Line 471: | ||
|Acute Myeloid Leukemia (AML) with t(4;12)(q12;p13); CHIC2-ETV6 | |Acute Myeloid Leukemia (AML) with t(4;12)(q12;p13); CHIC2-ETV6 | ||
|Disease | |Disease | ||
|Daynna Wolff+Path Resident | |Daynna Wolff+ Paige Woodham (Path Resident) | ||
|JH / MS | |JH / MS | ||
|PENDING | |PENDING | ||